As of April 16, 2025, Prestige Consumer Healthcare (PBH) has a market cap of $4.01 billion USD. According to our data, Prestige Consumer Healthcare is ranked No.2896 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $4.01 B |
3.65%
|
Dec 31, 2024 | $3.87 B |
27.56%
|
Dec 29, 2023 | $3.03 B |
-2.20%
|
Dec 30, 2022 | $3.10 B |
3.22%
|
Dec 31, 2021 | $3.00 B |
73.93%
|
Dec 31, 2020 | $1.73 B |
-13.90%
|
Dec 31, 2019 | $2.01 B |
31.15%
|
Dec 31, 2018 | $1.53 B |
-30.47%
|
Dec 29, 2017 | $2.20 B |
-14.76%
|
Dec 30, 2016 | $2.58 B |
1.20%
|
Dec 31, 2015 | $2.55 B |
48.27%
|
Dec 31, 2014 | $1.72 B |
-3.02%
|
Dec 31, 2013 | $1.77 B |
78.73%
|
Dec 31, 2012 | $0.99 B |
77.73%
|
Dec 30, 2011 | $0.56 B |
-5.69%
|
Dec 31, 2010 | $0.59 B |
52.04%
|
Dec 31, 2009 | $0.39 B |
-25.50%
|
Dec 31, 2008 | $0.52 B |
41.04%
|
Dec 31, 2007 | $0.37 B |
-42.55%
|
Dec 29, 2006 | $0.64 B |
4.16%
|
Dec 30, 2005 | $0.62 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Church & Dwight
CHD
|
$25.86 B |
-0.001 M
|
![]() USA
|
![]() Procter & Gamble
PG
|
$395.04 B |
0.016 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
![]() USA
|
![]() Colgate-Palmolive
CL
|
$76.45 B |
-0.001 M
|
![]() USA
|
![]() Unilever
UL
|
$152.67 B |
0.001 M
|
![]() UK
|
![]() Kimberly-Clark
KMB
|
$46.92 B |
-0.001 M
|
![]() USA
|
![]() GlaxoSmithKline
GSK
|
$72.32 B |
0.003 M
|
![]() UK
|
![]() Sanofi
SNY
|
$127.25 B |
3.672 B
|
![]() France
|
![]() Pfizer
PFE
|
$127.27 B |
-0.003 M
|
![]() USA
|
![]() Merck
MRK
|
$197.26 B |
0.003 M
|
![]() USA
|
![]() Bausch Health
BHC
|
$1.67 B |
-0.000 M
|
![]() Canada
|
![]() Perrigo
PRGO
|
$3.42 B |
-0.000 M
|
![]() Ireland
|
![]() Haleon
HLN
|
$45.67 B |
-0.001 M
|
![]() UK
|
Market Cap | = | PBH Stock Price | * | PBH Shares Outstanding |
= | $80.94 | * | 49.54 M | |
= | $4.01 B |